Clinical Results of Salvage Surgery in Hypopharyngeal, Cervical Esophageal and Laryngeal Cancer after Chemoradiotherapy

2012 ◽  
Vol 63 (6) ◽  
pp. 430-435 ◽  
Author(s):  
Hiroki Mitani ◽  
Kazuyoshi Kawabata
Toukeibu Gan ◽  
2008 ◽  
Vol 34 (4) ◽  
pp. 488-492 ◽  
Author(s):  
Hiroki Mitani ◽  
Masao Gakibuchi ◽  
Takayuki Asano ◽  
Hiroyuki Sakurai ◽  
Tomoyuki Kurita ◽  
...  

Head & Neck ◽  
1998 ◽  
Vol 20 (7) ◽  
pp. 630-633 ◽  
Author(s):  
Sergio Rodríguez-Cuevas ◽  
Sonia Labastida ◽  
Domingo Gonzalez ◽  
Nicolas Briseño ◽  
Hector Cortes

2011 ◽  
Vol 145 (5) ◽  
pp. 759-766 ◽  
Author(s):  
Jonathan J. Lusardi ◽  
Paula M. Buchanan ◽  
Kara M. Christopher ◽  
Mark A. Varvares

Objective. To find the survival rate of patients ≥80 years old who undergo salvage surgery for squamous cell carcinoma of the larynx. Study Design. National data registry analysis. Setting. Seventeen population-based registries comprising the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Subjects and Methods. Overall, cancer-specific, and relative survival rates were calculated from 1418 patients, stratified into 3 age cohorts, who underwent surgery following radiation therapy for treatment of laryngeal cancer. Results. The 1-year overall survival of patients ≥80 years old (n = 57) was 76.1%. The cancer-specific survival at 1 year was 86.4%. These survival rates were significantly less than those of patients <65 years old (n = 869), who had a 1-year overall survival of 88.1% ( P = .006) and cancer-specific survival of 90.5% ( P = .029). Patients aged between 65 and 79 years old (n = 492) displayed 1-year overall survival of 80.7% ( P = .426) and cancer-specific survival of 85.1% ( P = .711), which were not significantly different from the ≥80 year cohort. When comparing relative survival at 5 years, the ≥80-year-old cohort’s survival trended the highest (≥80 years, 62.8%; 65-79 years, 51.3%; 20-64 years, 56.2%). Conclusion. While patients ≥80 years old have a less favorable prognosis than patients <65 years old, the survival rates of patients ≥80 years old are not significantly different from the 65- to 79-year-old cohort. After controlling for non-cancer-related death, patients ≥80 years old appear to have similar 5-year survival outcomes compared with other patients.


Head & Neck ◽  
2017 ◽  
Vol 39 (10) ◽  
pp. 2021-2026 ◽  
Author(s):  
Kyle T. Fletcher ◽  
Thomas J. Gal ◽  
Andrew J. Ebelhar ◽  
Joseph Valentino ◽  
Yolanda M. Brill ◽  
...  

Toukeibu Gan ◽  
2007 ◽  
Vol 33 (3) ◽  
pp. 356-360 ◽  
Author(s):  
Yasushi Furuta ◽  
Akihiro Homma ◽  
Nobuhiko Oridate ◽  
Fumiyuki Suzuki ◽  
Hiromitsu Hatakeyama ◽  
...  

2006 ◽  
Vol 24 (4) ◽  
pp. 593-598 ◽  
Author(s):  
Susan Urba ◽  
Gregory Wolf ◽  
Avraham Eisbruch ◽  
Francis Worden ◽  
Julia Lee ◽  
...  

Purpose Primary chemoradiotherapy in patients with advanced laryngeal cancer can achieve high rates of organ preservation without sacrificing survival compared with radiation alone or conventional laryngectomy. Appropriate selection of patients for organ preservation approaches could enhance overall treatment outcome and quality of life. We conducted a phase II organ preservation trial for patients with stage III and IV larynx cancer to determine whether late salvage surgery rates could be decreased and survival improved by selecting patients for organ preservation based on response to a single cycle of induction chemotherapy. Patients and Methods The chemotherapy was cisplatin 100 mg/m2 on day 1 and fluorouracil 1,000 mg/m2/d for 5 days. Patients who achieved less than 50% response had immediate laryngectomy. Patients who achieved more than 50% response went on to concurrent chemoradiotherapy. Histologic complete responders after chemoradiotherapy received two more cycles of chemotherapy. Patients with residual disease after chemoradiotherapy had planned salvage surgery. Results Of 97 eligible patients, 73 (75%) achieved more than 50% response and received chemoradiotherapy. A total of 29 patients (30%) had salvage surgery; 19 patients (20%) had early salvage surgery after the single cycle of induction chemotherapy, three patients (3%) had late salvage surgery after chemoradiotherapy, six patients (6%) eventually had salvage surgery for recurrence, and one patient had laryngectomy for chondroradionecrosis. The median follow-up time was 41.9 months. The overall survival rate at 3 years is 85%. The cause-specific survival rate was 87%. Larynx preservation was achieved in 69 patients (70%). Conclusion These results confirm excellent larynx preservation and improved overall survival rates compared with historical results.


Sign in / Sign up

Export Citation Format

Share Document